Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Sanford-Burnham, Florida Hospital and Moffitt partner to develop PMP Florida

Moffitt Cancer Center, Sanford-Burnham Medical Research Institute and Florida Hospital have announced they will collaborate on the creation of a Personalized Medicine Partnership of Florida (PMP Florida). The partnership will conduct collaborative research to accelerate discovery and develop new treatments in the areas of cancer and metabolic diseases, including obesity, diabetes and cardiovascular disease.

9 Feb 2012

First study to examine how changes in fitness and fatness affect heart health

Good news for active adults fighting the battle of the bulge. Exercising and getting fit may protect your heart, even if you have a few extra pounds, according to a study published in the Feb. 14 issue of the Journal of the American College of Cardiology (JACC).

9 Feb 2012

Lawson Health Research Institute receives new hybrid imaging scanner

Imagine being able to detect Alzheimer's disease at its earliest stage and prescribe the proper medication to halt its progress. Imagine being able to evaluate the health of heart muscles and tissues after an attack and accurately prescribe treatment to prevent future heart failure. London is close to making these possibilities a reality with the installation of Canada's first whole body PET/MRI scanner at St. Joseph's Hospital, part of St. Joseph's Health Care London.

8 Feb 2012

ED can lead to potential cardiovascular disease in men

More than 12 million men have type 2 diabetes and that number is growing at an alarming rate. A little talked about complication of this disease is erectile dysfunction (ED), which can lead to an even more serious condition.

7 Feb 2012

DMPA intake may increase risk of periodontitis, gingivitis in women

Injectable progesterone contraceptives may be associated with poor periodontal health, according to research in the Journal of Periodontology. The study found that women who are currently taking depotmedroxyprogesterone acetate (DMPA) injectable contraceptive, or have taken DMPA in the past, are more likely to have indicators of poor periodontal health, including gingivitis and periodontitis, than women who have never taken the injectable contraceptive.

7 Feb 2012

New ACCP guidelines address DVT/PE risk factors for long-distance travel

New evidence-based guidelines from the American College of Chest Physicians (ACCP) address the many risk factors for developing a deep vein thrombosis (DVT), or blood clot, as the result of long-distance travel.

7 Feb 2012

Even minimal regular alcohol could harm health say experts

Television adverts are introduced to carry home the message that drinking just a little over the daily recommended alcohol limit can lead to serious health problems. Current medical advice states that men should drink a maximum of four units a day, with women advised to consume no more than three.

6 Feb 2012

Coronary patients with low levels of anti-PC at greater risk of complications

Coronary patients with low levels of an immune system antibody called anti-PC, which neutralises parts of the "bad" cholesterol, run a greater risk of suffering complications following an acute cardiac episode and thus of premature death.

6 Feb 2012

Takeda launches EDARBYCLOR in the U.S. for treatment of hypertension

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., announced EDARBYCLOR (azilsartan medoxomil and chlorthalidone) is now available by prescription in U.S. pharmacies for the treatment of hypertension to lower blood pressure in adults.

6 Feb 2012

Height, BMI in early childhood can contribute to adult bone mass and density

Researchers from the University of Southampton, in collaboration with a research group in Delhi, India, have shown that growth in early childhood can affect bone density in adult life, which could lead to an increased risk of developing bone diseases like osteoporosis.

3 Feb 2012

Study examines link between blood pressure and risk of ESRD under 'real world' conditions

An upward revision of the blood pressure numbers used to identify risk of end-stage renal disease (ESRD) might actually help doctors provide better care for their patients, said the authors of a study in patients with chronic kidney disease.

3 Feb 2012

FDA grants Mylan tentative approval for Atorvastatin Calcium ANDA

Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg.

3 Feb 2012

Complex PCI: Left Main and CTO Summit to be held Feb. 23-25

The final agenda is now available online for the Complex PCI: Left Main and CTO Summit at http://www.complexpci.com/conference/agenda.html. The Summit is a three-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions.

2 Feb 2012

NHLBI's The Heart Truth to showcase Red Dress Collection 2012 on Feb. 8

As part of American Heart Month, on Wednesday, Feb. 8, 2012, the National Heart, Lung, and Blood Institute's (NHLBI's) The Heart Truth campaign, with the support of the Foundation for the National Institutes of Health (FNIH), will showcase its signature event, the Red Dress Collection 2012 at Mercedes-Benz Fashion Week in New York City.

2 Feb 2012

Medtronic initiates enrollment in IMPROVE HF Bridge Study

Medtronic, Inc. today announced the initiation and first patient enrollment in a clinical study that will evaluate gaps in the implementation of evidence-based treatment guidelines among chronic heart failure patients post-hospital discharge.

From Medtronic 2 Feb 2012

Study finds wide variation in rates of diabetes across developing countries

Rates of diabetes vary widely across developing countries worldwide, according to a new analysis led by Dr. Longjian Liu of Drexel University's School of Public Health.

2 Feb 2012

Leading medical groups collaborate to ensure consistent, responsible uptake of TAVR

With the U.S. Food and Drug Administration's recent approval of transcatheter aortic valve replacement (TAVR) for patients with aortic valvular stenosis, the American College of Cardiology Foundation (ACCF), along with the American Association for Thoracic Surgery (AATS), the Society for Cardiovascular Angiography and Interventions (SCAI) and the Society of Thoracic Surgeons (STS), today released an expert consensus document to provide important guidance on its use.

1 Feb 2012

First signs of atherosclerotic heart disease may appear in early childhood

When we think about people with heart disease we usually think about middle-aged men. In reality, atherosclerotic heart disease is the leading cause of death for men and women in North America, but its impact starts much earlier than adulthood. Though children will rarely, if ever, have overt symptoms of atherosclerosis, the first signs of this disease appear in early childhood and perhaps even before birth.

1 Feb 2012

ESC welcomes 'intriguing' study on heart failure

The European Society of Cardiology (ESC) welcomes an "intriguing" study, published today in the Journal of the American College of Cardiology, featuring a completely novel approach for improving endothelial function in heart failure.

31 Jan 2012

Juventas' JVS-100 Phase I heart failure trial meets primary safety endpoint

Juventas Therapeutics is a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease. The Company's lead product, JVS-100, encodes Stromal cell-Derived Factor 1 (SDF-1) which has been shown to repair damaged tissue through recruitment of circulating stem cells to the site of injury, prevention of ongoing cell death and restoration of blood flow.

31 Jan 2012